Stress Management Intervention in Inner City Adolescents With Asthma

NCT ID: NCT01445015

Last Updated: 2011-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-07-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will utilize a stress management program delivered over 10 sessions that is hypothesized to result in decreased stress levels and improved coping strategies in an inner city adolescent asthma population. Participants will include adolescents ages 10-15 years with physician diagnosed asthma. The outcome measures will be obtained via psychosocial questionnaires and spirometry.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma Psychosocial Stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stress management program

Group Type EXPERIMENTAL

Stress management program

Intervention Type BEHAVIORAL

10 session intervention utilizing a cognitive behavorial program with a goal of stress reduction

peer viewed movies

Group Type ACTIVE_COMPARATOR

Peer viewed movies

Intervention Type OTHER

PG rated movies to be viewed over 10 sessions in peer setting

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stress management program

10 session intervention utilizing a cognitive behavorial program with a goal of stress reduction

Intervention Type BEHAVIORAL

Peer viewed movies

PG rated movies to be viewed over 10 sessions in peer setting

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 8-15 years of age
* Physician diagnosed asthma based on NHBLI guidelines
* English speaking
* Child assent/parental consent

Exclusion Criteria

* Refusal of child assent/parental consent
* Non-English speaking
* History of psychiatric illness, autoimmune disease, HIV/AIDs, smoking history.
Minimum Eligible Age

8 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Weill Medical College of Cornell University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lisa Moreno

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cornell Weill Pulmonary/Allergy pediatric clinics

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lisa Moreno, MD

Role: CONTACT

718-350-6680

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lisa Moreno, MD

Role: primary

718-350-6680

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5T32HS000066

Identifier Type: AHRQ

Identifier Source: org_study_id

View Link